Top Buy Stocks
Sign In
NASDAQ:AXGN
AxoGen Stock News
$11.78
-0.0400 (-0.338%)
At Close: May 15, 2025
AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates
09:30am, Thursday, 08'th May 2025
AxoGen (AXGN) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.06 per share a year ago.
Axogen, Inc. Reports 2025 First Quarter Financial Results
07:05am, Thursday, 08'th May 2025
ALACHUA, Fla. and TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, to
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025
08:04am, Thursday, 24'th Apr 2025
ALACHUA and TAMPA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today
Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript
01:58pm, Tuesday, 25'th Feb 2025
Axogen, Inc. (NASDAQ:AXGN ) Q4 2024 Earnings Conference Call February 25, 2025 8:00 AM ET Company Participants Michael Dale - Chairman and Chief Executive Officer Nir Naor - Chief Financial Officer Je
Axogen, Inc. To Host Analyst & Investor Day on March 4th
07:10am, Tuesday, 25'th Feb 2025
ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, w
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
04:58pm, Tuesday, 11'th Feb 2025
ALACHUA, Fla. and TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out?
10:36am, Monday, 13'th Jan 2025
AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last?
06:11am, Monday, 13'th Jan 2025
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Friday, 10'th Jan 2025
Craig Swandal, experienced medical device manufacturing executive, joins leadership team Craig Swandal, experienced medical device manufacturing executive, joins leadership team
Axogen: Well Placed To Capitalize Growth At Higher Multiples
08:01pm, Monday, 06'th Jan 2025
Axogen: Well Placed To Capitalize Growth At Higher Multiples
AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?
10:16am, Tuesday, 24'th Dec 2024
AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?
10:45am, Thursday, 19'th Dec 2024
Here is how AxoGen (AXGN) and Boston Scientific (BSX) have performed compared to their sector so far this year.
All You Need to Know About AxoGen (AXGN) Rating Upgrade to Buy
01:05pm, Thursday, 28'th Nov 2024
AxoGen (AXGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
How Much Upside is Left in AxoGen (AXGN)? Wall Street Analysts Think 31.18%
10:56am, Monday, 25'th Nov 2024
The mean of analysts' price targets for AxoGen (AXGN) points to a 31.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript
09:53am, Saturday, 09'th Nov 2024
Axogen, Inc (NASDAQ:AXGN ) Q3 2024 Results Conference Call November 7, 2024 8:00 AM ET Company Participants Michael Dale - Chairman and Chief Executive Officer Nir Naor - Chief Financial Officer Confe
